Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
Dr Xingui Liu has been awarded a Marie Skłodowska-Curie Fellowship to undertake research in the lab of Professor Alessio Ciulli in the newly established Centre for Targeted Protein Degradation (CeTPD).
News
How did life start out on this planet, around 3.5 billion years ago? Since we cannot go back in time to look we can only get hints by projecting backwards from contemporary life, and doing experiments that test the limits of what might have been possible.
News
William Farnaby has been appointed as Principal Investigator within the newly formed Centre for Targeted Protein Degradation (CeTPD).
News
A research publication by Tasuku Ishida and Alessio Ciulli has been named one of the 2021 SLAS Readers Choice Award winners.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
Dr Susan Wyllie, Head of the Mode of Action group within WCAIR and Principal Investigator in the School of Life Sciences, underwent a successful tenure review recently.
News
Joana Faria, a postdoctoral researcher in David Horn’s Lab (BCDD-WCAIR) who is moving to establish her own group at the University of York, has been awarded the Wellcome-Beit Prize.
Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
Press release
Scientists at the University of Dundee have developed a new technology that provides a greater understanding into the biology of ‘undruggable’ diseases.
News
Recently published papers from the Ferguson lab describe the presence of a fucosyltransferase in the mitochondria of two protozoan parasites
News
Glycosyltransferases (GTs) are enzymes that transfer sugars from donor to an acceptor molecule. There are dozens of GT gene families, classified by sequence, sequence motifs and enzymatic function.
Press release
The expansion of an exemplary industry-academia collaboration will see the University of Dundee intensify its efforts to develop new medicines that target and destroy key cancer-causing proteins, which have previously been regarded as undruggable
News
Joana Faria, a postdoctoral researcher in David Horn’s Lab (BCDD-WCAIR) has been awarded a Sir Henry Dale Fellowship funded by the Wellcome Trust and the Royal Society.
Press release
Almost half a million rapid diagnostic tests developed from research at the University of Dundee will be donated with the aim of helping eliminate the disease known as African sleeping sickness
Press release
A new translational research centre will bolster the University of Dundee’s world-leading position in a field that is revolutionising drug discovery, while helping to facilitate the development of high growth companies and create skilled jobs.
Press release
A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals.
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.
Press release
Work to build on Dundee’s world-class expertise in biomedical sciences is set to begin in earnest after the ‘Growing the Tay Cities Biomedical Cluster’ project was officially signed off by the Tay Cities Region Joint Committee today (February 19).
News
Michele Tinti, a postdoctoral researcher in Mike Ferguson’s lab, has competed on the international stage to search for a stable mRNA sequence in order to create a stable COVID-19 vaccine.